212 posters, 10 topics, 5 sessions, 754 authors, 237 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
The AAPS 101st Annual Meeting
29 April – 2 May, 2023 | Chicago, IL
D4
A National Analysis of Targeted Muscle Reinnervation Following Major Upper Extremity Amputation.
Poster Presenter
Authors
Lauren Valentine, BS, Allan A. Weidman, BS, Angelica Hernandez Alvarez, MD, Natalie Hassell, BA, Valeria P. Bustos, MD, Jose Foppiani, MD, Toni Engmann, Samuel J. Lin, MD, MBA, FACS, Sammy Dowlatshahi, MD
Affiliations
Beth Israel Deaconess Medical Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
Part of Topic
Hand/Extremity
Targeted Muscle Reinnervation Following Major Upper Extremity Amputation
Objectives: The evaluate national trends in the application of TMR following upper extremity amputation
-
Highlight disparities to push for further access to this treatment
-
Methods: Retrospective study
-
Healthcare Cost and Utilization Project’s Nationwide Inpatient Sample
-
Identified adult patients who underwent upper extremity amputations with and without subsequent TMR procedures from 2016-2019 using ICD-10 codes
-
Results: Total upper extremity amputations: n = 8,945 weighted encounters. 310 patients received TMR (3.5%) 245 males (68.9%), 65 females (21%)
-
Multivariable regression revealed no significant differences in hospital length of stay or hospital charges
• Conclusion:
-
Incidence of TMR is low (3.5%)
-
Patients who are younger, located in New England and receive care at government-controlled hospitals have a higher odds of receiving TMR
-
TMR at time of amputation results in no increased cost or length of stay
-
-
Further research should be directed to highlight the potential benefits of TMR and subsequently broaden patients’ access